Powered by AuraPulse+
100% Edge
• Camera initializing... 65s Target
Ready for Scan
Keep your face framed in the white brackets and remain still.
Timer: Ready
SQI: --/100
Lighting: --%
FPS: --
Align: Waiting
REAL-TIME PHOTOPLETHYSMOGRAM PULSE WAVEFORM (BVP) Plane-Orthogonal-to-Skin (POS)
Heart Rate & Zones ⚪ Waiting
-- BPM
Normal resting baseline (60-100 BPM)
Max HR: -- BPM Zone: --
Respiration & Mechanics ⚪ Waiting
-- RPM
Healthy eupnea range (12-20 RPM)
Pattern: Eupnea I:E Ratio: 1:1.6
Blood Pressure (SDPPG) ⚪ Waiting
-- / -- mmHg
AHA Clinical Guideline Stratification
MAP: -- mmHg b/a Ratio: --
Cardiac Flow & SVR 🔬 Flow Proxy
-- L/min (CO)
Estimated resting volumetric cardiac output
SVR: -- dyn·s/cm⁵ Norm: 4.5 - 7.0 L/min
Oxygen Saturation ⚪ Waiting
-- % SpO2
Dual-wavelength Ratio-of-Ratios
Ratio (R): -- Norm: 95-100%
HRV & Triangular Index ⚪ Waiting
-- ms (RMSSD)
Autonomic vagal recovery indicator
HRV-TI: -- TINN: -- ms
Baevsky Stress & Resilience ⚪ Waiting
-- SI
Sympathetic regulatory tension strain
Resilience: --/100 Norm: 50-150 SI
Training Readiness ⚪ Waiting
-- / 100
Composite autonomic recovery capacity
Allostatic Load: --/10 Peak: 75-100
VO2 Max & Fitness Age ⚪ Waiting
-- mL/kg/min
Jackson-Pollock Non-Exercise Model
Fitness Age: -- yrs Aerobic Capacity
Breathing Coherence ⚪ Waiting
-- % Coherent
Cardiorespiratory spectral alignment
Phase Shift: --° Target: >40%
Arrhythmia & Ectopic Screening ⚪ Waiting
-- Rhythm
Poincaré SD1/SD2 geometry & Entropy
PVC Burden: 0.0% CV: --%
Autonomic Balance (CVI / CSI) ⚪ Waiting
-- LF/HF Ratio
Sympathovagal spectral distribution
CVI: -- CSI: --
Cardiovascular 10-Year ASCVD & SCORE2 Projections
Low Risk (<10%)
Framingham ASCVD & ESC SCORE2 European Consensus
SCORE2: --%
Lifetime: --%
--%
Vascular Biological Age ⚪ Waiting
-- Years
Arterial compliance & Aging Index (AGI)
Delta: -- yrs Plaque: Low
TyG Insulin Resistance 🔬 TyG Index
-- Index
Triglyceride-Glucose metabolic product
TG/HDL: -- Target: < 4.65
Fasting Glucose Risk ⚪ Waiting
-- mg/dL
Multi-variate glycemic risk indicator
Target: <100 mg/dL VAI: --
HbA1c Glycemic Risk ⚪ Waiting
-- % HbA1c
Estimated 3-month glycemic exposure tier
MetS Z: -- Prediabetes: 5.7-6.4%
Hemoglobin (Hb) ⚪ Waiting
-- g/dL
Differential optical extinction model
Men: 14-18 / Women: 12-16 Optical Density
Body Composition (BMI) ⚪ Waiting
-- kg/m²
Anthropometric body roundness analysis
BRI: -- WHtR: --
POINCARÉ RETURN MAP (RRₙ vs RRₙ₊₁) SD1/SD2 Ellipse
DEMODULATED RESPIRATORY ENVELOPE RIBV Extraction
PHOTOPLETHYSMOGRAM SECOND DERIVATIVE (SDPPG / APG) Systolic Wave Contour (a, b, c, d, e)
Multi-Modal Sensor Fusion Hub (Bluetooth & Kiosk Telemetry) 4 Devices Ready
Bluetooth BP Cuff
● Connected
Omron / A&D Link
Medical Pulse Oximeter
● Paired
Nonin / Masimo BLE
Smart Body Scale
● Standby
Bioimpedance Auto-Sync
Infrared Thermometer
● Standby
Temporal Artery BLE
CLINICAL BIOMARKER & VITAL SIGNS REFERENCE STANDARDS (AGE 18+) Abnormal measurements may require clinical attention
Health Indicator & Description Normal Range (Age 18+) Health Issues Associated with Abnormal Levels
Blood Pressure
Arterial pressure during contraction/relaxation
Systolic: < 120 mmHg
Diastolic: < 80 mmHg
Heart attack, heart disease, stroke, kidney disease, poor cognitive function, dementia
Heart Rate / Pulse Rate
Resting heart beat frequency
60 – 100 BPM Stroke, heart failure, hypovolemia, fever, tachycardia (>100 bpm), bradycardia (<60 bpm)
Heart Rate Variability (HRV / RMSSD)
Inter-beat interval variance
Age 20–25: 55–105 ms
Age 60–65: 25–45 ms
Autonomic strain, physical exhaustion, elevated risk of cardiac events, sickness, sleep disturbance
Oxygen Saturation (SpO2)
Oxygen-carrying hemoglobin relative to total
95% – 100% Hypoxemia, heart disease, interstitial lung disease, COPD, anemia, ARDS, pneumonia, sleep apnea
Breathing / Respiration Rate
Breaths per minute
12 – 20 RPM Anxiety, fever, respiratory distress, tachypnea (>20 rpm), bradypnea (<12 rpm), COPD, asthma
Hemoglobin (Hb)
Total blood hemoglobin concentration
Men: 14 – 18 g/dL
Women: 12 – 16 g/dL
Anemia, sickle cell disease, chronic kidney disease, hematological disorders, acute blood loss
Hemoglobin A1c (HbA1c)
Estimated 2-3 month glycemic control
Normal: ≤ 5.7%
Prediabetes: 5.7% – 6.4%
Diabetes: > 6.4%
Prediabetes, Type 2 diabetes, metabolic syndrome, macrovascular complications, neuropathy
Fasting Blood Glucose (FBG)
Estimated fasting glycemic status
Normal: < 100 mg/dL
Impaired: 100 – 125 mg/dL
Elevated: > 125 mg/dL
Insulin resistance, metabolic syndrome, Type 2 diabetes, hepatic steatosis
Sympathetic Stress (Baevsky SI)
Central regulatory tension index
50 – 150 SI (Eustress) Acute mental/physical stress, cardiovascular overstrain, autonomic imbalance, fatigue
PNS Recovery Ability
Parasympathetic vagal tone
≥ 50 / 100 Delayed parasympathetic reactivation, chronic fatigue, systemic inflammatory stress
Pulse-Respiration Quotient (PRQ)
HR / RR coupling ratio
3.5 – 5.0 Cardiorespiratory mismatch, hyperventilation, autonomic dysregulation
10-Year ASCVD Risk
Likelihood of atherosclerotic event in 10 years
< 10% (Low Risk) Heart disease, stroke, peripheral artery disease, myocardial infarction
Vascular Biological Age
Arterial compliance biological age
Delta ≤ +1.0 years Arterial stiffening, endothelial dysfunction, accelerated cardiovascular aging